Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immuno...
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy
About this item
Full title
Author / Creator
Publisher
Basel: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Basel: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Cancer immunotherapy has revolutionized treatment and led to an unprecedented wave of immuno-oncology research during the past two decades. In 2018, two pioneer immunotherapy innovators, Tasuku Honjo and James P. Allison, were awarded the Nobel Prize for their landmark cancer immunotherapy work regarding “cancer therapy by inhibition of negative im...
Alternative Titles
Full title
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1effcf77853041a2abacd227d52e50a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1effcf77853041a2abacd227d52e50a8
Other Identifiers
ISSN
1423-0127,1021-7770
E-ISSN
1423-0127
DOI
10.1186/s12929-021-00746-2
